First Time Loading...

Lantheus Holdings Inc
NASDAQ:LNTH

Watchlist Manager
Lantheus Holdings Inc Logo
Lantheus Holdings Inc
NASDAQ:LNTH
Watchlist
Price: 75.835 USD -3% Market Closed
Updated: May 3, 2024

Lantheus Holdings Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lantheus Holdings Inc
Revenue Peer Comparison

Comparables:
HAE
COO
XRAY
ALGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Lantheus Holdings Inc
NASDAQ:LNTH
Revenue
$1.3B
CAGR 3-Years
56%
CAGR 5-Years
30%
CAGR 10-Years
16%
Haemonetics Corp
NYSE:HAE
Revenue
$1.3B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
3%
Cooper Companies Inc
NYSE:COO
Revenue
$3.7B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
9%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Revenue
$4B
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
3%
Align Technology Inc
NASDAQ:ALGN
Revenue
$3.9B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
19%

Lantheus Holdings Inc
Revenue Breakdown

Breakdown by Geography
Lantheus Holdings Inc

Not Available

Breakdown by Segments
Lantheus Holdings Inc

Total Revenue: 1.3B USD
100%
Product: 1.3B USD
97.4%
Radiopharmaceutical Oncology: 854.4m USD
65.9%
Pylarify: 851.3m USD
65.7%
Total Precision Diagnostics: 390.1m USD
30.1%
Definity: 279.8m USD
21.6%
Techne Lite: 87.4m USD
6.7%
Strategic Partnerships And Other: 51.9m USD
4%
License And Royalty Revenues: 33.4m USD
2.6%
Other Precision Diagnostics: 23m USD
1.8%
Other Radiopharmaceutical Oncology: 3.1m USD
0.2%
Show More
Show Less

See Also

What is Lantheus Holdings Inc's Revenue?
Revenue
1.3B USD

Based on the financial report for Dec 31, 2023, Lantheus Holdings Inc's Revenue amounts to 1.3B USD.

What is Lantheus Holdings Inc's Revenue growth rate?
Revenue CAGR 10Y
16%

Over the last year, the Revenue growth was 39%. The average annual Revenue growth rates for Lantheus Holdings Inc have been 56% over the past three years , 30% over the past five years , and 16% over the past ten years .